Alcedo completed the acquisition of a 64.2% of Ekalab for $42m.

Alcedo, a private equity firm, completed the acquisition of a 64.2% of Ekalab , a company active in the production and marketing of food supplements, nutraceuticals, phytotherapics, pharmaceuticals and medical devices, for $42m.